From molecules to decision.
DMPK, translational and drug development strategy.
What We Do
Drug Development Strategy
Develop an integrated program strategy from lead optimization through Phase 2 proof of concept. We define key studies, decision points, regulatory requirements, and timelines across nonclinical and clinical development.
IND & NDA Advisory
Drawing on experience supporting 8 INDs and 4 NDAs, we translate scientific evidence into clear regulatory strategy, submission content, and responses to FDA questions.
Scientific Due Diligence
Rigorous asset evaluation for investors, acquirers, and licensing teams. We surface what matters before you commit.
Portfolio & Pipeline Consulting
Prioritize programs and allocate resources based on scientific value, development risk, strategic fit, and funding needs – helping emerging biotech and pharma companies focus on the highest-value opportunities.
24+
Years of Experience
8
INDs Supported
4
NDAs Supported
Founder & Principal Advisor
Science. Strategy. Impact.
H2S Strategic Biosciences was built on the conviction that the best science deserves the clearest path to patients. With 24+ years guiding drug development programs from discovery through approval, our founder combines a strong foundation in biology from his biochemistry background with graduate studies in pharmaceutical and medicinal chemistry, deep DMPK/ADME expertise, and hands-on experience across quantitative modeling, translational science, nonclinical development, and regulatory strategy.
Whether you’re a pre-IND startup, a mid-stage company facing a regulatory inflection, or an investor conducting scientific due diligence – we meet you where you are and move you forward.
Ready to advance your program?
Let’s talk about where your drug development program stands and where it needs to go.
Engagements are confidential. We work with startups, biotechs, pharma, and investors.